Interleukin-10 fusion proteins and uses thereof
US10040843B2 · kind B2 · utility
3Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2016 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Apr 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to fusion proteins of antibodies and interleukin-10 (IL-10). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.